Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company
TOKYO & NEW YORK & DÜSSELDORF, Germany–(BUSINESS WIRE)–Asahi Kasei Corp. (TOKYO:3407) today announces that it will offer the shareholders of... Read more.
Phreesia Joins the MEDITECH Alliance Program as an Innovator Partner
ALL-REMOTE COMPANY/WILMINGTON, Del.–(BUSINESS WIRE)–Phreesia, a leader in patient intake, outreach, and activation, has joined the MEDITECH Alliance... Read more.
NEXT Golf Tour Champion Jordan Weber Tees It Up on DP World Tour
38-year-old American makes his first top-level tour start at the European Open on Thursday, May 30 HAMBURG, Germany–(BUSINESS WIRE)–Jordan Weber’s... Read more.
Spire Global to Join Russell 3000® Index
VIENNA, Va.–(BUSINESS WIRE)–$SPIR—Spire Global, Inc. (NYSE: SPIR) (“Spire” or “the Company”), a global provider of space-based data, analytics... Read more.
Merck Announces Phase 3 KEYNOTE-522 Trial Met its Overall Survival (OS) Endpoint in Patients With High-Risk Early-Stage Triple Negative Breast Cancer (TNBC)
KEYTRUDA® (pembrolizumab) is the first and only immunotherapy-based regimen to show a statistically significant improvement in OS as pre-operative (neoadjuvant)... Read more.
The BlackRock Foundation invests in Spartanburg Academic Movement to spur education and job readiness in Union County, South Carolina
With Union County Schools and other partners, SAM will develop cradle-to-career program to boost local workforce SPARTANBURG, S.C.–(BUSINESS WIRE)–Spartanburg... Read more.
CORE Industrial Partners Portfolio Company PrecisionX Group Acquires National Manufacturing
CHICAGO–(BUSINESS WIRE)–CORE Industrial Partners (“CORE”), a manufacturing, industrial technology, and industrial services-focused private equity... Read more.
Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program
Arcturus to present new Phase 1b interim data for ARCT-032 at European Cystic Fibrosis Conference on June 7, 2024 First four CF patients demonstrated an average... Read more.
IHS Towers Publishes 2023 Sustainability Report
LONDON–(BUSINESS WIRE)–IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of... Read more.
Arrowhead Pharmaceuticals Presents New Phase 2 Data of Plozasiran in Patients with Mixed Hyperlipidemia
– Plozasiran significantly lowered triglyceride levels with commensurate reductions in APOC3, non-HDL-C, and remnant cholesterol – Data presented at... Read more.